Home dialysis
The right therapy at the right time and place
In chronic kidney disease, there is not one perfect therapy that can be applied to all patients. It’s about choosing the right therapy at the right time and place and continuously adapting it to the needs of the patient. With our vision of reaching smart decision-making support, state-of-the-art therapies and patient management tools, we bring home to life.
Your partner in home dialysis solutions –
We bring home to life
With our expertise, we aim to offer more than state-of- the-art therapies. From the decision-making process, training solutions and the start of the treatment to the everyday management of dialysis, we are here to support you every step of the patient pathway. Fresenius Medical Care wants to be your partner in home dialysis, via offering a range of solutions for both peritoneal dialysis (PD) and home hemodialysis (HHD) as well as services to support you, the associated clinical and practical solutions. We provide full support throughout the patient’s pathway – and during all modality changes. With our high standards, we provide you with a comprehensive portfolio to improve outcomes for your patients while fulfilling their personal preferences.
Click on the therapies to get more information about our therapy offerings
In addition to technology - supporting care along the patient pathway
Together with HCPs we have developed different guidance tools which support you in your daily job to offer potential treatment options for every patient independently of time and location. Our aim is to support you making every therapy option as good as possible for the patient and therefore develop tools along the patient pathway. In the following table, you can find our solutions for transition patients, who are about to start or change therapy.
With our portfolio for predialysis and dialysis patients, we want to provide you with a broad range of tools you can utilize to offer the right therapy to your patients along the patient pathway.
Chronic kidney disease and transition
Chronic kidney disease (CKD) is a worldwide public health problem. Its prevalence in Europe is as high as 5.9 patients for every 100 people (CKD3-CKD5).5 An especially critical period in the CKD patient care pathway is when kidney function declines to the stage, where renal replacement therapy (RRT) is required. This transition phase requires complex treatment decisions from a patient, which includes choosing RRT modality.6,7 Shared decision-making helps physicians find the best therapy fit.8
Inform & Decide - Comprehensive information for profound shared decision making
Every patient is unique and so is their therapy. By offering the complete scope of treatment options in home-, as well as center-based-dialysis, we have the expertise to support your therapy decision – based on the patient’s needs. FMC can support you with comprehensive patient education materials and therapy decision support to support the modality choice conversation with patients and help to choose the right therapy for every patient.
In this section:
1 Jaquet S et al. Can J Kidney Health Dis 2019
2 Pike E et al. The Norwegian Institute of Public Health (NPH) 2013
3 Manns BJ et al. Kidney Int 2005; 68(4):1777-83
4 Wu HHL et al. Hemodial Int 2021; 25(4):416-423
5 Brück K et al. J Am Soc Nephrol 2016; 27(7):2135-2147
6 Green JA et al. Adv Chronic Kidney Dis 2016; 23:231-239
7 Wagner LA et al. Semin Nephrol 2017; 37:194-208
8 Yu X et al. Kidney Int Rep 2021;7(1):15-27